Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Biotech
Galapagos halts lupus CAR-T work, confirms 100 layoffs this year
Galapagos used its earnings report to disclose that work has been halted on a CD19 CAR-T candidate for refractory systemic lupus erythematosus.
James Waldron
Feb 23, 2024 8:28am
Galapagos to find new small molecules for cancer with BridGene
Jan 3, 2024 4:01pm
J&J's medtech chief out the door—Chutes & Ladders
Oct 27, 2023 9:30am
Amgen poaches Moderna CMO—Chutes & Ladders
Jun 16, 2023 9:30am
Galapagos, following Sanofi's playbook, offloads R&D site to CRO
Mar 31, 2023 8:30am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am